These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community. Dunlay SM; Killian JM; Roger VL; Schulte PJ; Blecker SB; Savitz ST; Redfield MM J Card Fail; 2022 Oct; 28(10):1500-1508. PubMed ID: 35902033 [TBL] [Abstract][Full Text] [Related]
8. Impact of Pharmacist-Led Heart Failure Clinic on Optimization of Guideline-Directed Medical Therapy (PHARM-HF). Patil T; Ali S; Kaur A; Akridge M; Eppes D; Paarlberg J; Parashar A; Jarmukli N J Cardiovasc Transl Res; 2022 Dec; 15(6):1424-1435. PubMed ID: 35501544 [TBL] [Abstract][Full Text] [Related]
9. Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fraction. McCullough PA; Mehta HS; Barker CM; Van Houten J; Mollenkopf S; Gunnarsson C; Ryan M; Cork DP Clin Cardiol; 2021 Sep; 44(9):1192-1198. PubMed ID: 34342033 [TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry. Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971 [TBL] [Abstract][Full Text] [Related]
11. Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry. Peri-Okonny PA; Mi X; Khariton Y; Patel KK; Thomas L; Fonarow GC; Sharma PP; Duffy CI; Albert NM; Butler J; Hernandez AF; McCague K; Williams FB; DeVore AD; Patterson JH; Spertus JA JACC Heart Fail; 2019 Apr; 7(4):350-358. PubMed ID: 30738978 [TBL] [Abstract][Full Text] [Related]
12. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden). Savarese G; Bodegard J; Norhammar A; Sartipy P; Thuresson M; Cowie MR; Fonarow GC; Vaduganathan M; Coats AJS Eur J Heart Fail; 2021 Sep; 23(9):1499-1511. PubMed ID: 34132001 [TBL] [Abstract][Full Text] [Related]
13. Guideline-directed medical therapy in patients undergoing transcatheter edge-to-edge repair for secondary mitral regurgitation. Higuchi S; Orban M; Adamo M; Giannini C; Melica B; Karam N; Praz F; Kalbacher D; Koell B; Stolz L; Braun D; Näbauer M; Wild M; Doldi P; Neuss M; Butter C; Kassar M; Ruf T; Petrescu A; Ludwig S; Pfister R; Iliadis C; Unterhuber M; Sampaio F; Ferreira D; Thiele H; Baldus S; von Bardeleben RS; Massberg S; Windecker S; Lurz P; Petronio AS; Lindenfeld J; Abraham WT; Metra M; Hausleiter J; Eur J Heart Fail; 2022 Nov; 24(11):2152-2161. PubMed ID: 35791663 [TBL] [Abstract][Full Text] [Related]
14. Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients. Srivastava PK; DeVore AD; Hellkamp AS; Thomas L; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Duffy CI; Hernandez AF; Fonarow GC JACC Heart Fail; 2021 Jan; 9(1):28-38. PubMed ID: 33309579 [TBL] [Abstract][Full Text] [Related]
15. Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction. Lee YC; Lin JK; Ko D; Cheng S; Patorno E; Glynn RJ; Tsacogianis T; Kim DH J Am Geriatr Soc; 2023 Oct; 71(10):3110-3121. PubMed ID: 37345734 [TBL] [Abstract][Full Text] [Related]
16. Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy. Malgie J; Clephas PRD; Brunner-La Rocca HP; de Boer RA; Brugts JJ Heart Fail Rev; 2023 Sep; 28(5):1221-1234. PubMed ID: 37311917 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial. Ben-Yehuda O; Shahim B; Chen S; Liu M; Redfors B; Hahn RT; Asch FM; Weissman NJ; Medvedofsky D; Puri R; Kapadia S; Sannino A; Grayburn P; Kar S; Lim S; Lindenfeld J; Abraham WT; Mack MJ; Stone GW J Am Coll Cardiol; 2020 Dec; 76(22):2595-2606. PubMed ID: 33243380 [TBL] [Abstract][Full Text] [Related]
18. Long-term impact of angiotensin receptor-neprilysin inhibitor based on short-term treatment response in heart failure. Park HK; Park JS; Kim MS; Lee E; Choi H; Park YJ; Park BE; Kim HN; Kim N; Bae MH; Lee JH; Park HS; Cho Y; Jang SY; Yang DH ESC Heart Fail; 2023 Dec; 10(6):3430-3437. PubMed ID: 37705397 [TBL] [Abstract][Full Text] [Related]
19. Harnessing the Potential of Primary Care Pharmacists to Improve Heart Failure Management. Slade J; Lee M; Park J; Liu A; Heidenreich P; Allaudeen N Jt Comm J Qual Patient Saf; 2022 Jan; 48(1):25-32. PubMed ID: 34848159 [TBL] [Abstract][Full Text] [Related]
20. Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction. Sumarsono A; Xie L; Keshvani N; Zhang C; Patel L; Alonso WW; Thibodeau JT; Fonarow GC; Van Spall HGC; Messiah SE; Pandey A Circulation; 2024 Feb; 149(7):510-520. PubMed ID: 38258605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]